Dr. Benton qualified as a general and mental health nurse at the then Highland College of Nursing and Midwifery in Inverness, Scotland. His M Phil research degree focused on the application of computer-assisted learning to post-basic nurse education. He has, during the past 30 years published articles in relation to research, practice, education, leadership, regulation, and policy topics. He has a Ph.D. Summa Cum Laude from the University of Completeness for his work researching an international comparative analysis of the regulation of the nursing practice.
Dr. Benton has held senior roles for 25 years across a range of organizations. These roles have included working as Executive Director of Nursing at a Health Authority in London, as a senior civil servant in Northern and Yorkshire Region, as Chief Executive of a Nurse Regulatory body in Scotland, and as Nurse Director of a University Trust Health System.
Dr. Benton is the recipient of several awards and honors. He is particularly proud of being awarded the inaugural Nursing Standard Leadership award in 1993. He was presented with Fellowship of the Florence Nightingale Foundation in 2001, awarded Fellowship of the Royal College of Nursing in 2003 for his contribution to health and nursing policy, and most recently became a Fellow of the American Academy of Nursing in 2015.
Dr. Raber is a member of the faculty at the University of Southern California School of Pharmacy where he teaches classes in site-specific pharmacy practice, pharmacy standards of care, and pharmacy law. He is also a faculty member of PBI Education, a Jacksonville, Florida-based company specializing in continuing education and license remediation for healthcare professionals, where he teaches classes in pharmacy law and ethics.
Dr. Raber is an active member of the American Society of Health-System Pharmacists, California Society of Health-System Pharmacists, Academy of Managed Care Pharmacy, American College of Clinical Pharmacy, American Medical Writers Association, American Society for Healthcare Risk Management, Southern California Association for Healthcare Risk Management, and the American Society for Pharmacy Law.
Recently, He has oriented his research toward establishing neural features associated with consciousness. he is leading a multimodal PET/fMRI study of brain mechanisms associated with the serotonin psychedelic psilocybin, to better understand how this promising and broadly applicable therapeutic affects the brain. He is collaborating with neurologists at Rigshospitalet including a project evaluating fMRI measures in coma patients to identify neural markers of conscious awareness and recovery.
This section has yet to be updated by the user.